Literature DB >> 1687922

Detrimental effects of beta-adrenergic stimulation on beta-adrenoceptors and microtubules in the heart.

M Hori1, Y Koretsune, H Sato, T Kagiya, A Kitabatake, T Kamada.   

Abstract

Increased plasma catecholamines - in particular, excessive beta-adrenoceptor activation in chronic heart failure - may easily desensitize the beta-adrenoceptors as well as the postreceptor signal transductions. Since these detrimental changes in the failing heart could be reversible, administration of low-dose beta-blocker, which minimizes the negative inotropic effects, may be effective in attenuating the harmful effects of sympathetic nerve activation. Beta-adrenoceptor stimulation may also produce microtubule disruptions of the cell either through direct action or through an increase in heart rate. Treatment with beta-blockers could attenuate Ca overload by slowing the heart rate and may be useful as a protection from the structural disintegration of the cell. Thus, to clarify the underlying mechanisms of beta-blocker therapy for chronic heart failure, we have to consider not only to the functional aspects but also to the structural changes of the cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687922     DOI: 10.1007/bf01752531

Source DB:  PubMed          Journal:  Heart Vessels Suppl        ISSN: 0935-736X


  31 in total

1.  Control of microtubule assembly-disassembly by calcium-dependent regulator protein.

Authors:  J M Marcum; J R Dedman; B R Brinkley; A R Means
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure.

Authors:  P W Armstrong; T P Stopps; S E Ford; A J de Bold
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

3.  Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating.

Authors:  P Simpson
Journal:  Circ Res       Date:  1985-06       Impact factor: 17.367

4.  Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure.

Authors:  D E Vatner; S F Vatner; A M Fujii; C J Homcy
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

5.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

Authors:  F Waagstein; A Hjalmarson; E Varnauskas; I Wallentin
Journal:  Br Heart J       Date:  1975-10

6.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

7.  Selective desensitization of cardiac beta adrenoceptors by prolonged in vivo infusion of catecholamines in rats.

Authors:  H Y Chang; R M Klein; G Kunos
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

8.  Rapid agonist-induced decrease of 125I-pindolol binding to beta-adrenergic receptors. Relationship to desensitization of cyclic AMP accumulation in intact heart cells.

Authors:  J Linden; A Patel; A M Spanier; W B Weglicki
Journal:  J Biol Chem       Date:  1984-12-25       Impact factor: 5.157

9.  Recovery from heart failure: structural and functional analysis in a canine model.

Authors:  R J Howard; T P Stopps; G W Moe; A Gotlieb; P W Armstrong
Journal:  Can J Physiol Pharmacol       Date:  1988-12       Impact factor: 2.273

10.  Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines.

Authors:  P Simpson; A McGrath; S Savion
Journal:  Circ Res       Date:  1982-12       Impact factor: 17.367

View more
  1 in total

Review 1.  Beta-adrenergic blockade in dilated cardiomyopathy, ischemic cardiomyopathy, and other secondary cardiomyopathies.

Authors:  F Waagstein
Journal:  Heart Vessels Suppl       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.